Associate Vice President
Merck & Co., Inc.
Dr. Rosa Sanchez obtained a Ph.D. in Toxicology at Rutgers University and is currently Associate Vice President and Global DMPK Head in the Department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB) at Merck & Co., Inc., where she leads an organization that provides support for programs from the lead identification stage through candidate selection and clinical development. Dr. Sanchez’s team contributes to discovery programs through optimization of ADME properties and providing clinical dose projections for preclinical candidates across modalities (small molecules, peptides, biologics) and therapeutic areas. Her team also provides expert input through clinical development and have contributed support and scientific expertise to the development and filing of several products, including DELSTRIGO, LAGEVRIO, WELIREG, PREVYMIS and WINREVAIR. Dr. Sanchez has been a co-author in over 50 publications and is currently a member of the Board of Directors in the International Consortium for Innovation and Quality (IQ).
Saturday, May 31, 2025
8:30 AM - 3:00 PM East Coast USA Time